A Treatment Option for Patients with Metastatic Squamous NSCLC Who Progressed After Platinum-Based Chemotherapy

This article is sponsored and developed by Boehringer Ingelheim Pharmaceuticals


Read Now

In this supplement to Federal Practitioner ,
Dr. Raja Mudad, MD, discusses:

  • The burden of squamous non-small cell lung cancer among active United States military and veterans
  • Available treatment options for advanced metastatic squamous NSCLC
  • Clinical trial data surrounding a treatment for patients with metastatic squamous NSCLC who have progressed after platinum-based chemotherapy, that can be used as early as second-line

(06/20) PC-US-115598

Read Now

Next Article: